Business
AstraZeneca COVID-19 vaccine trial volunteer ‘had neurological symptoms’ – Sydney Morning Herald
A woman in the trial in the UK had symptoms consistent with a rare but serious spinal inflammatory disorder, according to a report.
AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine, Stat News has reported.
The participant was recovering and will likely be discharged from the hospital within a day, according to Stat News, which said on Wednesday the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors partici…
-
Noosa News12 hours agoLight plane crashes in Norwell, Gold Coast
-
General11 hours agoRAAF, or Richard Marles’ Airways? The Defence Minister’s flight of fancy
-
General12 hours agoPilbara mining towns left out of government’s battery rebate schemes
-
Business15 hours agoBerkshire Hathaway is a Scrooge stock. Will it have a change of heart and start paying dividends in 2026?